Biomarkers · Chemical

DHEA (Dehydroepiandrosterone) Unconjugated

Understand what DHEA (Dehydroepiandrosterone) Unconjugated signals

LOINC codes: 1763-2, 2143-6, 2196-4, 2837-3
Commercial laboratory assays: 2

We have not added a physiological summary for this biomarker yet. Compare the commercial laboratory assays and population reference ranges below.

Compare commercial laboratory assays for DHEA (Dehydroepiandrosterone) Unconjugated

Check orderable catalog codes, specimen types, fasting requirements, and demographic reference ranges across laboratories.

CAH Panel 6 (StAR Deficiency)

Laboratory: Quest Diagnostics
Test code: 15276
Specimen: Serum
Fasting: Not stated
LOINC: 1763-2, 2143-6, 2196-4, 2837-3

Laboratory assay overview

Steroidogenic acute regulatory protein (StAR) catalyzes the initial rate-limiting in the formation of steroid hormones. Affected individuals present with deficiency of cortisol and aldosterone, as well as early precursors in the synthesis of steroid hormones (Pregnenalone; DHEA (Dehydroepiandrosterone). Additional testing may be required to establish a diagnosis.

View complete laboratory reference notes

See Laboratory Report

Quest Diagnostics test directory, test code 15276

DHEA, (Dehydroepiandrosterone), Unconjugated

Laboratory: Quest Diagnostics
Test code: 19894
Specimen: Serum
Fasting: Not stated
LOINC: 2196-4
Turnaround: Set up: Mon, Wed, Fri (a.m.)

Laboratory assay overview

DHEA is a weakly androgenic steroid that is useful when congenital adrenal hyperplasia is suspected. It is also useful in determining the source of androgens in hyperandrogenic conditions, such as polycystic ovarian syndrome and adrenal tumors.

Quest Diagnostics population reference ranges

Quest Diagnostics calculates these statistical intervals for this specific assay and demographic group, not as universal optimal targets.

Population	Range
Males	147-1760 ng/dL
Females	not stated
Pre-Menopausal	not stated
Mid Follicular	385-1143 ng/dL
Surge	345-2030 ng/dL
Mid Luteal	414-1295 ng/dL
Post-Menopausal	77-851 ng/dL
1-11 months	≤327 ng/dL
1 year	≤269 ng/dL
2 years	≤244 ng/dL
3 years	≤253 ng/dL
4 years	≤297 ng/dL
5 years	≤376 ng/dL
6 years	≤487 ng/dL
7 years	≤616 ng/dL
8 years	34-744 ng/dL
9 years	45-854 ng/dL
10 years	56-950 ng/dL
11 years	67-1041 ng/dL
12 years	78-1120 ng/dL
13 years	86-1176 ng/dL
14 years	90-1207 ng/dL
15 years	95-1241 ng/dL
16 years	103-1294 ng/dL
17 years	113-1360 ng/dL

View complete laboratory reference notes

Adult Males | 147-1760 ng/dL Females Pre-Menopausal Mid Follicular | 385-1143 ng/dL Surge | 345-2030 ng/dL Mid Luteal | 414-1295 ng/dL Post-Menopausal | 77-851 ng/dL Pediatric 1-11 months | ≤327 ng/dL 1 year | ≤269 ng/dL 2 years | ≤244 ng/dL 3 years | ≤253 ng/dL 4 years | ≤297 ng/dL 5 years | ≤376 ng/dL 6 years | ≤487 ng/dL 7 years | ≤616 ng/dL 8 years | 34-744 ng/dL 9 years | 45-854 ng/dL 10 years | 56-950 ng/dL 11 years | 67-1041 ng/dL 12 years | 78-1120 ng/dL 13 years | 86-1176 ng/dL 14 years | 90-1207 ng/dL 15 years | 95-1241 ng/dL 16 years | 103-1294 ng/dL 17 years | 113-1360 ng/dL

Quest Diagnostics test directory, test code 19894

Verify these ranges and sources

We compile every detail above directly from named laboratory directories and published clinical studies. Laboratories calculate standard reference intervals from the statistical distribution of tested populations for a specific assay method and demographic group, rather than setting universal optimal targets.

Always review your personal lab results with a licensed clinician, or track your lab history and health goals in Aumnivida.

Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.